Ree drug distribution by government of India fading the bright future of Indian pharmaceutical sector

Government introduces free delivery of drugs in Indian State Hospitals from October. The doctors are forced to prescribe generic drugs, the salt names not the brand names and low price drugs. It adds on another hurdle for the Indian pharmaceutical companies as their sales are reducing. As a result the companies are following the strategy of downsizing the sales force (wholeseller, retailer, medical representatives). Now the sales personnel are facing job insecurity and increase workload. But downsizing is merely a cure and the companies have to focus on searching preventions for long term survival. In this paper I have tried to provide some of the preventions viz. Smart pricing strategies; managing total quality and better branding. This tri-layer-prevention will provide a long term survival for the company into the market where MNC's (multi-national companies) are flourishing as well as dominating. There is still a segment market which gives priority to private hospital treatment the only thing they need is moderate cost with good quality. By satisfying this segment through the mantra of tri-layer-prevention companies can achieve a substantial productivity.